A circadian shift in neutrophil activity can minimize heart-dattack damage
But here’s where the clockwork of your immune system matters most: neutrophils, the body’s frontline white blood cells, are not constant in their hustle. They follow a daily rhythm, peaking during the day and slowing at night, which means they can inflict more collateral injury to healthy tissue when they’re most active. Modulating this timing could open new avenues to limit damage from inflammatory events like heart attacks.
Biology unfolds in rhythms governed by an internal clock. Digestive enzymes surge around meals, sleep hormones rise as night falls, and body temperature shifts at dawn. Immune responses aren’t immune to this timing either, which helps explain why heart-attacks, for example, can be more damaging in the morning than later in the day.
Neutrophils are the body’s rapid responders. They swarm to injury sites to kill invaders and restore sterility, but sometimes they stay too long and release toxic compounds that harm nearby healthy cells. A new study from Yale School of Medicine, published December 12 in the Journal of Experimental Medicine, identifies the molecular switches that govern the neutrophil clock. The researchers also show that tweaking the circadian rhythms of these cells in mice can spare healthy tissue from injury during a heart attack.
Neutrophils aren’t mindless destroyers, says Andrés Hidalgo, PhD, a professor of immunology at Yale and senior author of the study. “They have a sense of time. They use it to know when to be active and where to go.” In a prior investigation, Hidalgo and colleagues traced the clockwork of neutrophils to two molecular levers: Bmal1, a transcription factor that activates neutrophils during the day, and CXCR4, a receptor that dampens neutrophil activity and is more active at night.
The idea is simple but powerful: daytime neutrophils operate with greater vigor, so their actions often cause more tissue damage. If researchers can tamp down neutrophil activity at key moments, they might reduce collateral injury during events like heart attacks.
In the new work, the team examined health records from 2,043 heart-attack patients. They found a link between neutrophil levels and injury severity: patients who suffered a heart attack in the morning, when neutrophils tend to be higher, showed more cardiac damage than those who had one at night.
This observation led to a test in mice. When the researchers deprived neutrophils of Bmal1, daytime neutrophil activity dropped, and cardiac injury decreased. They repeated the experiment with mice engineered to boost CXCR4 function, an approach that also protected the heart. Hidalgo describes this as two layers of control over neutrophil behavior.
To visualize how neutrophils behave inside inflamed vessels, the team used a four‑dimensional imaging setup. During the day, neutrophils tended to be stationary and pressed against vessel walls—an inflammatory posture associated with more severe injury. At night, however, neutrophils were more mobile, similar to non-inflamed conditions, suggesting less potential for collateral damage.
An intriguing finding came from a compound called ATI2341, which activates CXCR4. When applied, neutrophils shifted toward the nighttime behavior even during the day. Hidalgo emphasizes this as a dial you can turn: dialing neutrophils from a hyper-aggressive mode to a more restrained one without blunting their ability to fight infections.
This approach offers a notable advantage: it reduces harmful bystander effects without compromising the neutrophils’ pathogen-killing capabilities. The potential translation is a preventive therapy that lowers the risk of heart-attack–related damage by timing or pharmacologically modulating neutrophil activity.
As Hidalgo cautions, there are questions to answer. Could dialing down neutrophils come with trade-offs in other immune functions? The researchers are exploring these possible costs while recognizing the broader implication: circadian regulation is a fundamental component of immunity, and harnessing it could influence outcomes in cancer, sepsis, and neurodegenerative diseases as well.
In short, shifting the activity window of neutrophils could be a key strategy to reduce tissue damage during inflammatory injuries. Whether through clock disruption or targeted CXCR4 activation, adjusting immune timing holds promise for safer responses to heart attacks and beyond.
What do you think about timing-based immune therapies? Do you find the idea of pharmacologically dialing immune cells compelling or concerning? Share your thoughts in the comments.
Note: This summary is based on the study supported by NIH awards R01HL069438 and R01HL116340 and additional institutional support. The content reflects the authors’ interpretations and does not necessarily represent official NIH positions.
